T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review

T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review

Ovarian cancer, in particularly high-grade serous ovarian cancer (HGSOC) and ovarian carcinosarcoma (OCS), are highly aggressive and deadly female cancers with limited treatment options. These tumors are generally unresponsive to immune check-point inhibitor (ICI) therapy and are referred to as immu...

Descrición completa

Detalles Bibliográficos
Main Authors: Jessica W. Y. Wu, Sudiksha Dand, Lachlan Doig, Anthony T. Papenfuss, Clare L. Scott, Gwo Ho, Joshua D. Ooi
Formato: Artigo
Idioma:English
Publicado: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
T-cell receptor
tumor neoantigen
cell-based therapy
ovarian cancer
immunotherapy
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fimmu.2021.672502/full

Títulos similares

Títulos similares